Thank you for your inquiry.
We will contact you within a few business days.
(Business Unit Performance Materials, Sales Support Team)
Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia
+62 21 2988 8557
Success! Your inquiry has been submitted to our Sales team.
Something went wrong! Please try after some time.
We have found 46 items.
| Requestor's contact details | |
| Full name | |
| Company | |
| Position | |
| Telephone number | |
| Work email address | |
| Shipping address | |
Thank you. Your request has been sent.
PRAVASTATINE SODIUM is a drug used to lower the amount of cholesterol in the blood and to prevent stroke and heart attack. It is also being studied in the treatment of cancer and other conditions. Pravastatin sodium blocks an enzyme that helps make cholesterol in the body.
Atorvastatin Calcium, provided by Refarmed Chemicals, is a potent pharmaceutical ingredient used by healthcare professionals in the management and prevention of several cardiovascular-related conditions. As an integral part of the statin class of medications, Atorvastatin Calcium serves a critical role in reducing cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, apolipoprotein B, and total cholesterol. It is also effective in lowering triglyceride levels and is indicated for the prevention of cardiovascular events such as ischemic strokes and transient ischemic attacks, particularly in patients who are at high risk of these events. This product is especially valuable for the treatment of familial heterozygous and homozygous hypercholesterolemia. However, it is contraindicated in individuals with known hypersensitivity to the active ingredient, those suffering from active liver disease, and should not be used during pregnancy and breastfeeding due to potential risks. Formulated as a white or almost white yellowish crystalline powder, Atorvastatin Calcium comes with comprehensive documentation and certifications, such as the Certificate of Suitability (CEP) and Good Manufacturing Practice (GMP) standards, ensuring its quality and safety. The material's purity is rigorously controlled, with an assay requirement of 98.0% to 102.0%, minimal water content, and strict limits on enantiomer impurities as well as residual solvents such as Methanol and Methyl tert-butyl ether, as specified in the provided image of its typical properties. Patients prescribed Atorvastatin Calcium should be under close medical supervision to monitor liver function and signs of muscle damage, a potential adverse effect. Muscle pain, diarrhea, nausea, headache, and flatulence are among the commonly reported side effects. Moreover, Atorvastatin Calcium can interact with several other medications, necessitating careful review by healthcare professionals when determining a patient's regimen. Refarmed Chemicals' rigorous adherence to quality and patient safety, as exemplified by their Atorvastatin Calcium product, fulfills the expectation of effectiveness and reliability desired by healthcare providers and wholesalers looking to distribute a product that can make a significant impact on public health.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Refarmed Chemicals, as a distinguished member of the pharmaceutical industry, introduces Finasteride—a vital medication primarily utilized for the treatment of male pattern hair loss, also known as androgenetic alopecia. This condition is common in adult men and involves a receding hairline coupled with thinning of the hair on the crown and temple, often resulting in baldness. Finasteride works effectively by inhibiting the action of dihydrotestosterone (DHT), a hormone with a significant role in promoting hair loss. Finasteride is presented as an oral tablet, with dosing options of either 1mg or 5mg. It is designed to be consumed once daily, and its effectiveness is optimal when taken consistently over time. Adherence to the prescribed dosage is crucial, as is awareness of its strictly adult male usage parameters, as outlined by its contraindications. Produced in full compliance with Good Manufacturing Practice (GMP) standards and verified through various analytical quality control measures, the medication is a white or almost white, crystalline powder. It displays excellent solubility across ethanol, methanol, and methylene chloride, ensuring efficient absorption when ingested. The substance maintains a high purity, with the assay indicating a 98.0% - 102.0% content of the active ingredient, Finasteride, and has tight controls on impurities to ensure patient safety. Further considering safety, it is pivotal to acknowledge the contraindications and side effects Finasteride might present, such as decreased libido and erectile dysfunction. It's also necessary to take precautionary measures regarding potential interactions with other medications and its inappropriate use in women or children, as well as during pregnancy and breastfeeding. For optimal results and patient safety, tablets should be stored in controlled room temperatures, shielded from light and moisture. Our commitment to quality transcends the meticulously crafted tablets to encompass our service and reliability. We extend a partnership towards delivering growth in healthcare, ensuring that our prospective customers receive a product that balances robust efficacy with comprehensive safety measures.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Tulobuterol base is a high-grade bronchodilator, primarily used for managing respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This potent pharmaceutical ingredient is engineered to target and activate beta-2 adrenoreceptors in the airways, resulting in the relaxation of bronchial smooth muscles and effective bronchodilation. Refarmed Chemicals, a key player in the pharmaceutical industry and now part of the DKSH Group, manufactures Tulobuterol base with a commitment to excellence, as evidenced by compliance with EU GMP certifications and stringent quality controls. The product is presented as a white crystalline powder, with its consistency and purity validated by a comprehensive series of tests including IR, HPLC, and TLC tests. At the onset of use, Tulobuterol base exhibits rapid action within 5-15 minutes and sustains its therapeutic effect for up to 6 hours. Its main application is for the relief and prevention of bronchospasm in patients, thereby improving airway obstruction and lung function. Administered via an aerosol inhaler or nebulizer, dosage and frequency are tailored to individual patient needs and disease severity. The product's reliability is reinforced by its exhaustive assay, showing a 98.5% - 102% active ingredient range, with controlled levels of impurities and residual solvents. Safety is a core aspect of Tulobuterol base's design, having been tested for adverse components. Common side effects may include tachycardia and nervousness, among others. Caution is advised for patients with cardiovascular disease, hypertension, and diabetes. Tulobuterol base is contraindicated for individuals with hypersensitivity to beta-adrenergic agonists, those with thyrotoxicosis or tachyarrhythmias, and it is not recommended for use in children under 12 years of age. As with all medications, potential drug interactions need to be considered, notably with beta-blockers and other beta-adrenergic agonists. This product serves as a testament to Refarmed Chemicals' dedication to providing superior pharmaceutical materials. Through their integration with DKSH, they strive to deliver growth in Asia and beyond, ensuring the availability of quality medical compounds to healthcare providers and patients worldwide.
Products still subject to third-party patent protection might be available solely for R&D purposes.